Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Stent wars: Researchers report a tie, of sorts, for Medtronic’s Resolute and Abbott’s Xience V DES
Mass Device
Wednesday, July 3, 2013 - 3:30pm
tags:
stent, research, Medtronic, devices, Abbott
Volcano extends deadline for $3M milestone payment for Crux Biomedical
Mass Device
Wednesday, July 3, 2013 - 3:29pm
tags:
Volcano, Crux Biomedical, devices, Milestone
GI Dynamics hauls in $52.2M to get obesity tech through FDA
FierceMedicalDevice
Wednesday, July 3, 2013 - 3:27pm
tags:
GI Dynamics, FDA, obesity, regulatory, devices
Positive Data for Baxter's Advate
Yahoo/Zacks
Wednesday, July 3, 2013 - 3:25pm
tags:
Baxter, Advate, data
Guided Therapeutics Continues to Await Update from FDA on Its PMA Application for LuViva® Advanced Cervical Scan
Yahoo/BusinessWire
Wednesday, July 3, 2013 - 3:23pm
tags:
Guided Therapeutics, FDA, PMA, LuViva, cervical
Baxano to pay $6M in Medicare fraud settlement
Yahoo/AP
Wednesday, July 3, 2013 - 3:19pm
tags:
Baxano, Medicare fraud, legal
Fresenius Wins U.S. Appeal Over Baxter Hemodialysis Patent
Bloomberg
Wednesday, July 3, 2013 - 3:18pm
tags:
Fresenius, Baxter, patent, legal
Mesa Labs Acquires the SureTorque Product Line
Yahoo/PRNewswire
Wednesday, July 3, 2013 - 3:16pm
tags:
Mesa Labs, SureTorque, M&A
Paladin Labs to acquire antibiotic from Bayer
The Globe and Mail, Canada
Wednesday, July 3, 2013 - 11:57am
tags:
Bayer, antibiotics, Paladin, Binotal, Latin America
FDA grants priority review to Roche's leukemia drug
Reuters
Wednesday, July 3, 2013 - 11:52am
tags:
FDA, Roche, GA101, chronic lymphocytic leukemia
Is This Pharmaceutical Giant About To Lose Its Cornerstone Drug?
Motley Fool
Wednesday, July 3, 2013 - 11:50am
tags:
Celltrion, Hospira, Remicade, JNJ
Mead Johnson Falls Most in 18 months on China Milk Probe
Bloomberg
Wednesday, July 3, 2013 - 11:45am
tags:
China, Mead Johnson, infant formula
Alliance Pharma says unlikely to regain full market share for ImmuCyst
Yahoo/Reuters
Wednesday, July 3, 2013 - 11:43am
tags:
Alliance Pharma, ImmuCyst, bladder cancer
Why AstraZeneca plc's Patent Cliff Presents A Golden Opportunity
Motley Fool
Wednesday, July 3, 2013 - 11:26am
tags:
patent cliff, AstraZeneca
Will An Acquisition Boost Pfizer?
Wall St. Cheat Sheet
Wednesday, July 3, 2013 - 11:12am
tags:
Pfizer, M&A, ONYX Pharmaceuticals
Sanofi's Lyxumia Gets Japanese Nod
Yahoo/Zacks
Wednesday, July 3, 2013 - 11:11am
tags:
Sanofi, Lyxumia, Japan, diabetes
Merck: Implications Of Capital Allocation
Seeking Alpha
Wednesday, July 3, 2013 - 11:07am
tags:
Bristol-Myers Squibb, Eli Lilly, AstraZeneca, Merck, capital allocation
Glaxo J&J Combination May Control HIV With Monthly Injections
Bloomberg
Wednesday, July 3, 2013 - 11:05am
tags:
GSK, JNJ, HIV, GSK744, TMC278
Vivus's top shareholder proposes former AstraZeneca exec as CEO
Reuters
Tuesday, July 2, 2013 - 9:45am
tags:
Vivus, AstraZeneca, Anthony Zook
Covidien wraps spinoff of drug unit
Fierce Biotech
Tuesday, July 2, 2013 - 9:44am
tags:
spinoffs, Covidien, Mallinckrodt

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.